Montag A & Associates Inc. Invests $6.85 Million in SPDR S&P Biotech ETF $XBI

Montag A & Associates Inc. purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 56,147 shares of the exchange traded fund’s stock, valued at approximately $6,846,000.

A number of other large investors have also recently made changes to their positions in the stock. JPMorgan Chase & Co. grew its stake in shares of SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after acquiring an additional 2,900,633 shares during the period. Bessemer Group Inc. grew its stake in shares of SPDR S&P Biotech ETF by 9.3% in the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after acquiring an additional 138,322 shares during the period. Ameriprise Financial Inc. grew its stake in shares of SPDR S&P Biotech ETF by 40.5% in the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after acquiring an additional 353,351 shares during the period. Meitav Investment House Ltd. grew its stake in shares of SPDR S&P Biotech ETF by 70.3% in the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after acquiring an additional 281,602 shares during the period. Finally, Greenhouse Funds LLLP grew its stake in shares of SPDR S&P Biotech ETF by 16.6% in the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after acquiring an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.7%

Shares of XBI stock opened at $130.42 on Friday. The company has a 50 day moving average price of $127.98 and a 200-day moving average price of $122.74. SPDR S&P Biotech ETF has a 52 week low of $75.68 and a 52 week high of $139.19. The firm has a market capitalization of $8.32 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.